MedPath

Efficacy and safety of bimatoprost 0.01% for the treatment of eyebrow hypotrichosis: A randomized, double-blind, vehicle-controlled study

Phase 3
Completed
Conditions
Eyebrow hypotrichosisMadarosis
Registration Number
TCTR20160911001
Lead Sponsor
Division of Dermatology, Ramathibodi Hospital, Mahidol University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

1.Healthy male and female subject
2.Diagnosis of eyebrow hypotrichosis
3.Agree to participate and signed informed consent form

Exclusion Criteria

1.History of eyebrow transplant
2.Applying topical hair growth products within 2 weeks
3.Receiving light and laser treatment of the eyebrow within 3 months
4.Taking oral medication influenced hair within 6 months
5.History of systemic illness
6.Pregnancy or breast feeding

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of topical 0.01% bimatoprost solution 6 months Hair count and hair diameter
Secondary Outcome Measures
NameTimeMethod
Safety of topical 0.01% bimatoprost solution 6 months Erythema, Scaliness, Inflammation and Hyperpigmentation
© Copyright 2025. All Rights Reserved by MedPath